Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

Abstract excerpt

The introduction of new agents and regimens for the treatment of chronic hepatitis C, such as pegylated interferons and combination therapy with ribavirin, has resulted in substantial improvements in sustained virologic response rates. However, treatment remains a challenge, particularly for certain patient populations, because several virus-related and patient-related factors are associated with a lower...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Confounding Factors, Epidemiologic
• Share to Drug Therapy, Combination